Emergency Medicine: Open Access

Emergency Medicine: Open Access
Open Access

ISSN: 2165-7548

+44 1223 790975

Case Report - (2015) Volume 5, Issue 3

The Ultrasonography Image of Abdominal Fat

Roever L*, Diniz ALD and Resende ES
Department of Clinical Research, Federal University of Uberlândia, Brazil
*Corresponding Author: Roever L, Department of Clinical Research, Federal University of Uberlândia, Leonardo S. Roever-Borges, MHS, Av. Pará, 1720 – Bairro Umuarama, CEP– 38400-90e – CP 59, Brazil, Tel: 553488039878 Email:

Description

The metabolic syndrome is a complex clustering of cardiometabolic abnormalities associated with aging, physical inactivity, poor diet, insulin resistance and diabetes and abdominal adiposity [1-9].

The incidence of obesity has increased dramatically during recent decades. Obesity increases the risk for metabolic and cardiovascular diseases and premature death. Adipose tissue of the obese expresses increased amounts of proinflammatory proteins such as TNF-α, IL-6, TGF-β, IL-10, C-reactive protein, soluble ICAM, and monocyte chemotactic protein-1 (MCP-1), and procoagulant proteins such as plasminogen activator inhibitor type-1 (PAI-1), tissue factor, and factor VII [10-18].

The researchers found that abdominal subcutaneous fat (Figure 1) was at least as strong a correlate of insulin sensitivity as visceral fat and retained independent significance after adjusting for visceral fat (Figure 2). Visceral adipose tissue accumulations are well known correlates of metabolic complications predictive of increased risk of type II diabetes, hypertension, coronary heart disease and heart failure [19-21].

emergency-medicine-subcutaneous-fat

Figure 1: The thickness of the subcutaneous fat.

emergency-medicine-visceral-fat

Figure 2: The thickness of visceral fat.

The perirenal ultrasonographic fat (Figure 3) thickness measurement may better reflect the risks commonly associated with increased visceral fat accumulation and particularly those related to renal function impairment, microalbuminuria, hypertension and uricaemia. The perirenal adipose tissue has been shown to compress renal vessels and renal parenchyma, causing elevated renal interstitial hydrostatic fluid, and reductions in both renal blood and tubular flow rate [22-26].

emergency-medicine-perirenal-fat

Figure 3: The thickness of the perirenal fat.

The subcutaneous fat thickness was measured with a 7.5 MHz linear transducer transversely positioned 1 cm above the umbilical scar. For the visceral fat, a 3.5 MHz transducer was also positioned 1 cm above the umbilical scar, considering the distance between the internal surface of the abdominal rectus muscle and the posterior aortic wall in the abdominal midline. The perirenal fat was measured in the middle third of the right kidney, with the transducer positioned at the axillary midline [27-38].

Magnetic resonance imaging (MRI) and Computed Tomography ( CT) can accurately quantify the volumes of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) and shows good accuracy with ultrasonography. But its cost and need for specialized personnel limits their use.

Ultrasonography (US) has been shown to be an alternative, noninvasive, reliable method to estimate these fat compartments. Abdominal fat thickness is an independent predictor of metabolic syndrome, diabetes, hypertension, kidney dysfunction and uricaemia. Abdominal fat it is associated with metabolic risk factors for cardiovascular disease.

References

  1. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, et al. (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 2087-2094.
  2. Diniz, ALD, Roever L, Pinto RMC (2009) Reproducibility of ultrasonography as a method to measure abdominal and visceral fat. Radiol Bras 42: 353-357
  3. Armellini F, Zamboni M, Robbi R, Todesco T, Rigo L, et al. (1993) Total and intra-abdominal fat measurements by ultrasound and computerized tomography.Int J ObesRelatMetabDisord 17: 209-214.
  4. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. (2015) Heart disease and stroke statistics-2015 update: a report from the american heart association.Circulation 131: e29-29e322.
  5. Mongraw-Chaffin ML, Anderson CA, Allison MA, Ouyang P, Szklo M, et al. (2015) Association between sex hormones and adiposity: Qualitative differences in women and men in the Multi-Ethnic Study of Atherosclerosis.J ClinEndocrinolMetab .
  6. Faria G, Gonçalves A, Cunha R, Guimarães JT, Calhau C, et al. (2015) Beyond central adiposity: Liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients.Int J Surg 14: 75-79.
  7. Katsuyama H, Kawaguchi A, Yanai H2 (2015) Not visceral fat area but the ratio of visceral to subcutaneous fat area is significantly correlated with the marker for atherosclerosis in obese subjects.Int J Cardiol 179: 112-113.
  8. Efe D, Aygün F, Acar T, Yildiz M, Gemici K3 (2014) Investigation of relation between visceral and subcutaneous abdominal fat volumes and calcified aortic plaques via multislice computed tomography.Vascular .
  9. Rosenquist KJ, Massaro JM, Pedley A, Long MT, Kreger BE, et al. (2015) Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality.J ClinEndocrinolMetab 100: 227-234.
  10. Tchernof A, Després JP (2013) Pathophysiology of human visceral obesity: an update.Physiol Rev 93: 359-404.
  11. Blüher M, Mantzoros CS2 (2015) From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century.Metabolism 64: 131-145.
  12. Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z5 (2015) Adiponectin as a potential biomarker of vascular disease.Vasc Health Risk Manag 11: 55-70.
  13. Blüher M1 (2014) [Adipose tissue--an endocrine organ].Internist (Berl) 55: 687-697.
  14. Lasselin J, Magne E, Beau C, Ledaguenel P, Dexpert S, et al. (2014) Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss.J ClinEndocrinolMetab 99: E53-61.
  15. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.Science 259: 87-91.
  16. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults.JAMA 282: 2131-2135.
  17. Samad F, Pandey M, Loskutoff DJ (1998) Tissue factor gene expression in the adipose tissues of obese mice.ProcNatlAcadSci U S A 95: 7591-7596.
  18. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance.ProcNatlAcadSci U S A 100: 7265-7270.
  19. Nazare JA, Smith J, Borel AL, Aschner P, Barter P, et al. (2015) Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study).Am J Cardiol 115: 307-315.
  20. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.Diabetes 46: 1579-1585.
  21. You T, Ryan AS, Nicklas BJ (2013) The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation. The Journal of Clinical Endocrinology & Metabolism 89: 11.
  22. Kawasaki S, Aoki K, Hasegawa O, Numata K, Tanaka K, et al. (2008) Sonographic evaluation of visceral fat by measuring para- and perirenal fat.J Clin Ultrasound 36: 129-133.
  23. Rea DJ, Heimbach JK, Grande JP, Textor SC, Taler SJ, et al. (2006) Glomerular volume and renal histology in obese and non-obese living kidney donors.Kidney Int 70: 1636-1641.
  24. Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, et al. (2011) Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients.Nephrol Dial Transplant 26: 892-898.
  25. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, et al. (2011) Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation.Am J Physiol Renal Physiol 301: F1078-1087.
  26. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, et al. (2010) Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events.Hypertension 56: 901-906.
  27. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, et al. (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases.Int J ObesRelatMetabDisord 28 Suppl 4: S58-65.
  28. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, et al. (2001) Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue.Int J ObesRelatMetabDisord 25: 1346-1351.
  29. Armellini F, Zamboni M, Robbi R, Todesco T, Rigo L, et al. (1993) Total and intra-abdominal fat measurements by ultrasound and computerized tomography.Int J ObesRelatMetabDisord 17: 209-214.
  30. Armellini F, Zamboni M, Rigo L, Todesco T, Bergamo-Andreis IA, et al. (1990) The contribution of sonography to the measurement of intra-abdominal fat.J Clin Ultrasound 18: 563-567.
  31. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, et al. (2004) Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases.Am J ClinNutr 79: 593-599.
  32. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, et al. (1993) Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen.Am J Med 95: 309-314.
  33. Ross R, Rissanen J (1994) Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise.Am J ClinNutr 60: 695-703.
  34. Thomas EL, Saeed N, Hajnal JV, Brynes A, Goldstone AP, et al. (1998) Magnetic resonance imaging of total body fat.J ApplPhysiol (1985) 85: 1778-1785.
  35. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM (1997) Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J ClinNutr 65: 403-408.
  36. Gong W, Ren H, Tong H, Shen X, Luo J, et al. (2007) A comparison of ultrasound and magnetic resonance imaging to assess visceral fat in the metabolic syndrome.Asia Pac J ClinNutr 16: 339-345.
  37. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, et al. (2004) Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.Int J ObesRelatMetabDisord 28: 1018-1025.
  38. Wagner DR (2013) Ultrasound as a tool to assess body fat.J Obes 2013: 280713.
Citation: Roever L, Diniz ALD, Resende ES (2015) The Ultrasonography Image of Abdominal Fat. Emerg Med (Los Angel) 5: 246.

Copyright: © 2015 Roever L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top